August 17, 2021 August 17, 2021Categories Active Clinical TrialsNow Enrolling: EA8184 for Prostate CancerThis phase II study is testing the effects and safety of green tea catechins (GTC) as a chemopreventive agent
![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
